[Featured Stock] JinMatrix Rises on Government's Push to Import UK COVID-19 Vaccine
[Asia Economy Reporter Minwoo Lee] Jin Matrix's stock price is on the rise. The news that the government is pushing to import the United Kingdom's novel coronavirus (COVID-19) vaccine has highlighted the fact that it has invested in related companies.
As of 9:35 a.m. on the 5th, Jin Matrix's stock price recorded 15,000 won, up 5.65% from the previous day. Around 9:08 a.m., it rose more than 10% to 15,750 won.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- [Reporter’s Notebook] On Teachers’ Day, the Urgent Need for the Teacher’s Role Over ‘Integration’
- Woman in Her 50s Found Dead 28 Days After Going Missing on Bukhansan Mountain
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
The news that the government is negotiating special import arrangements with the British pharmaceutical company AstraZeneca to import the vaccine from the University of Oxford's Jenner Institute in the future appears to have acted as a positive factor. Previously, Jin Matrix invested 4 million pounds (about 5.7 billion won) in 2018 in Vaxcyte, a spin-off from the University of Oxford. Professor Adrian Hill, the founder and board member of Vaxcyte, is the director of the Jenner Institute and is actively conducting clinical research with multinational pharmaceutical companies.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
